Analysis of hematological parameters of COVID-19 / SARS-CoV-2 positive patients treated at a university hospital in northeastern Brazil




SARS-CoV-2 Infection; Hematological disease; Intensive care unit; Severe acute respiratory syndrome; Hemoglobin A.


The objective of this work was to analyze the hematological parameters of patients positive for COVID-19, admitted to the COVID intensive care unit (ICU-COVID) of the University Hospital Lauro Wanderley (HULW), to correlate these data with the clinical conditions of critically ill patients, compared to patients in the ward of the COVID Infectious Parasitic Diseases Unit (IDP -COVID). The study population consisted of patients in (ICU-COVID) and (IDP-COVID) of both genders, considering children, adolescents, adults, and elderly people hospitalized in this unit with positive serology or molecular tests (RT-PCR). This was a retrospective observational cross-sectional study involving patients in the (ICU-COVID) and (IDP -COVID) of the HULW. The study was carried out in accordance with the requirements of the Research Ethics Committee (CAAE 46718921.4.0000.5183) of the HULW. 152 exams were analyzed. Of these, 88 (58%) were male and the average in relation to the age group was 61.5 years. By correlating the data obtained from inpatients in the COVID-ICU and IDP-COVID, it can be observed in the ICU-COVID patients there was the predominance of leukocytosis (50.4%), as well as lymphopenia (90.9%), neutrophilia (80%) and anemia (70%). Thrombocytopenia is present in 23% of patients in the COVID-ICU and alterations in Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) were identified. These data corroborate the literature, in which the total leukocyte count varies between patients, which may reflect the dominance of lymphopenia or neutrophilia. Taken together, decreased lymphocytes accompanied by mild thrombocytopenia are among the most common abnormal findings that attract attention in the blood count of COVID-19 patients.


Agbuduwe, C., Basu, S. Haematological manifestations COVID-19: Fromcytopenia of to coagulopathy. European Journal of Haematology. 2020 Nov;105(5):540-546. DOI: 10.1111/ejh.13491. PMID: 32663356; PMCID: PMC7404736.

Aragão Neto, H. de C., Costa, C. M., Pita, J. C. L. R., Castro, R. D. de, Vasconcelos, I. R. A., & Benedito, R. B. (2021). Epidemiological and laboratory profile of patients confirmed with Covid-19 and admitted to a reference hospital. Research, Society and Development, 10(15), e421101523067.

Dong, X., Cao Y., Lu X., Zhang J., Du, H., Yan,Y., &Akdis, C.A. Eleven faces of coronavirus disease 2019. Allergy, v. 75, n. 7, pp. 1699–1709, 2020.

Fan, B. E., Chong, V. C. L., & Chan, S. S. W. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. v. 95, n. 6, pp. 131–134, 2020.

Gao, Y., Li T., Han, M.,Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X. & Wang, L.Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol, v. 92, n. 7, pp. 791–796, 2020.

Gorbalenya, A.E., Baker, S.C., Baric, R.S., Groot, R.J., Drosten, C., Gulyaeva, A.A., Haagmans, B.L., Lauber, C., Leontovich, A.M., Neuman, B.W., Penzar, D., Perlman, S., Poon, L.L.M., Samborskiy, D.V., Sidorov, I.A., Sola, I.,& John Ziebuhr, J. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology. Nature, v. 5, n. 4, pp. 536-544, 2020.

Hamming, I., Goor, H.V., Turner, A.J., Rushworth, C.A., Michaud, A.A., Corvol, P., &Navis, al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: A first step in understanding SARS pathogenesis. J Pathol. v. 203, pp. 631-637, 2004

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J.,& Cao, B.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. v. 395, pp. 497-506, 2020.

Johns Hopkins University & Medicine: Coronavirus resource center.Covid-19. <>. Acessado em: 25 de abril de 2020.

Lam, J.C.M., Moshi,G.B., Ang, S.H., Cheu, H.M., Ng, Q.H., Madjukie,A.,&Logeswary, M. Management of COVID-19-related paediatric blood samples in a clinical haematology laboratory. Br J Haematol. 2020 Jun; 189(5):848-85. doi: 10.1111/bjh.16721. E pub 2020 May 9. PMID: 32297317; PMCID: PMC7262170.

Lippi, G., &Olebani, M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.ClinChem Lab Med,v. 50, n. 7, pp. 1063-1069, 2020.

Lu, H., Stratton, C. W., & Tang, Y. W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol, v. 92, n. 4, pp. 401-402, 2020.

Lu, R., Zhao, X., & Li, J. Genomic characterization, and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. v. 395, p. 565-574, 2020.

Monteiro, J. C. M. S., Guimarães,H. O., Oliveira,, Cordeiro,H. P., Cordeiro,F. de N. C. dos S., Araújo F. C.,&Mendonça,L. T. Desordens hematológicas autoimunes e infecção pelo SARS-CoV-2: revisão de literatura. Revista Eletrônica Acervo Saúde, 13(11), e9110.

Paul, S., Rausch, C. R., Jain, N., Kadia, T., Ravandi, F., Dinardo, C. D., Welch, M. A., Dabaja, B. S., Daver, N., Garcia-Manero, G., Wierda, W., Pemmaraju, N., Montalban Bravo, G., Thompson, P., Verstovsek, S., Konopleva, M., Kantarjian, H., &Jabbour, E.TreatingLeukemia in the time of COVID-19. Acta Haematologicav. 11, pp. 1-13, 2020.

Pourbagheri-Sigaroodi, A., Bashash, D., Fateh, F.,&Abolghasemi, H. Laboratory findings in COVID-19 diagnosis and prognosis. ClinChim Acta. 2020 Nov; 510:475-482. doi: 10.1016/j.cca.2020.08.019. Epub 2020 Aug 14. PMID: 32798514; PMCID: PMC7426219.

Relatórios de situação de doença por coronavírus (COVID-19). <>. Acessado em: 3 set. 2020.

Taneri, P.E., Gómez-Ochoa, S.A., Llanaj, E., Raguindin, P.F., Rojas, L.Z., Roa-Díaz, Z.M., Salvador, D. Jr., Groothof, D., Minder, B., Kopp-Heim, D., Hautz W.E.,Eisenga, M.F., Franco, O.H., Glisic, M.,&Muka, T. Anemia andironmetabolism in COVID-19: a systematicreviewand meta-analysis. Eur J Epidemiol. 2020 Aug;35(8):763-773. doi: 10.1007/s10654-020-00678-5. Epub 2020 Aug 20. PMID: 32816244; PMCID: PMC7438401.

Wang, W., Xu,Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. Detection of SARS-CoV-2 in different types of clinical specimens. J Am Med Assoc. v. 323, n. 18, pp. 1849-1844, 2020.

Worldometer. Coronavirus Update (Live): 3,515,743 Cases and 245,617 Deaths from COVID-19 Virus Pandemic. <> Acessado em: 03 de maio de 2020.

Yamada, T., Wakabayashi, M., Yamaji, T., Chopra, N., Mikami, T., Miyashita, H., & Miyashita, S. Valueofleukocytosisandelevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. ClinChimActa. 2020 Oct; 509:235-243. doi: 10.1016/j.cca.2020.06.008. Epub 2020 Jun 10. PMID: 32533986; PMCID: PMC7832771.

Zhou, P., Yang, X. L., &Wang, X. G. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. v. 579, pp. 270-273, 2020.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Tan, W. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. v. 382, pp. 727-733, 2020.

Ziegler, C. G. K., Allon, S. J., & Nyquist, S. K. SARS-COV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. v. 181, pp. 1016-1035, 2020.




How to Cite

CUNHA , S. M. D. da .; ALVES, C. A. .; SILVA, I. B. da .; OLIVEIRA FILHO, A. A. de .; CORREIO, F. C. N. .; CUNHA, S. M. D. da .; ARAGÃO NETO, H. de C. . Analysis of hematological parameters of COVID-19 / SARS-CoV-2 positive patients treated at a university hospital in northeastern Brazil. Research, Society and Development, [S. l.], v. 11, n. 6, p. e41711629012, 2022. DOI: 10.33448/rsd-v11i6.29012. Disponível em: Acesso em: 12 jul. 2024.



Health Sciences